(WELL) Welltower - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US95040Q1040

Senior Housing, Wellness Communities, Real Estate

Health Care REITs
Market Cap in USD: 127,712m

IPO / Inception: 2001-01-02
Return 12m vs S&P 500: 24.7%

EPS (Earnings per Share)

EPS CAGR: -36.58%
EPS Trend: 50.8%

Last SUE: -3.55
Qual. Beats: 0

Revenue

Rev. CAGR: 21.45%
Rev. Trend: 97.8%

Last SUE: -0.41
Qual. Beats: 0

Dividends

Dividend Yield	1.52%
Yield on Cost 5y	5.27%
Yield CAGR 5y	3.68%
Payout Consistency	97.5%
Payout Ratio	1.8%

Risk via 5d forecast
Volatility	20.5%
Value at Risk 5%th	33.5%
Relative Tail Risk	-0.38%

Reward TTM
Sharpe Ratio	1.79
Alpha	43.77
CAGR/Max DD	2.76

Character TTM
Hurst Exponent	0.525
Beta	0.298
Beta Downside	0.433

Drawdowns 3y
Max DD	15.05%
Mean DD	2.81%
Median DD	1.90%

Description: WELL Welltower December 02, 2025

Welltower Inc. (NYSE: WELL) is an S&P 500-listed REIT that concentrates on senior-focused rental housing and wellness communities across the United States, United Kingdom, and Canada. The company describes itself as a hybrid “operating company in a real-estate wrapper,” leveraging data-science-driven capital allocation and the proprietary Welltower Business System to generate long-term per-share growth for shareholders.

Key operational metrics (as of Q3 2024) show an occupancy rate of roughly 94% and adjusted funds from operations (AFFO) of $1.23 per share for FY 2024, reflecting a 7% year-over-year increase. The pipeline includes more than 30 new or redeveloped communities slated for completion by 2026, primarily in “micro-markets” with strong senior population growth; the U.S. 65-plus cohort is projected to rise from 56 million in 2023 to 78 million by 2035, underpinning demand. A sector-wide driver is the prevailing low-interest-rate environment, which supports REIT valuation through compressed cap rates, though any upward shift in rates could pressure pricing and financing costs.

For a deeper quantitative breakdown and scenario analysis, the ValueRay platform offers a concise, data-rich view of WELL’s valuation dynamics.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (958.0m TTM) > 0 and > 6% of Revenue (6% = 588.6m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 91.01% (prev 73.19%; Δ 17.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.05 (>3.0%) and CFO 2.79b > Net Income 958.0m (YES >=105%, WARN >=100%)

Net Debt (11.36b) to EBITDA (3.50b) ratio: 3.24 <= 3.0 (WARN <= 3.5)

Current Ratio 5.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (685.4m) change vs 12m ago 10.85% (target <= -2.0% for YES)

Gross Margin 39.21% (prev 39.38%; Δ -0.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 18.09% (prev 15.02%; Δ 3.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.49 (EBITDA TTM 3.50b / Interest Expense TTM 602.6m) >= 6 (WARN >= 3)

Altman Z'' 0.27

(A) 0.15 = (Total Current Assets 10.96b - Total Current Liabilities 2.03b) / Total Assets 59.50b

(B) -0.15 = Retained Earnings (Balance) -8.75b / Total Assets 59.50b

(D) -0.40 = Book Value of Equity -8.28b / Total Liabilities 20.48b

Total Rating: 0.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 62.19

1. Piotroski 3.0pt

2. FCF Yield 1.99%

3. FCF Margin 28.26%

4. Debt/Equity 0.47

5. Debt/Ebitda 3.24

6. ROIC - WACC (= -3.43)%

7. RoE 2.73%

8. Rev. Trend 97.75%

9. EPS Trend 50.83%

What is the price of WELL shares?

As of January 12, 2026, the stock is trading at USD 186.08 with a total of 2,274,206 shares traded.
Over the past week, the price has changed by +0.73%, over one month by +0.60%, over three months by +11.96% and over the past year by +50.61%.

Is WELL a buy, sell or hold?

Welltower has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy WELL.

Strong Buy: 10
Buy: 6
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the WELL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	208.7	12.2%
Analysts Target Price	208.7	12.2%
ValueRay Target Price	259.3	39.4%

WELL Fundamental Data Overview January 12, 2026

P/E Trailing = 128.331
P/E Forward = 78.7402
P/S = 12.89
P/B = 3.2952
P/EG = 3.6218
Beta = 0.857
Revenue TTM = 9.81b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 3.50b USD
Long Term Debt = 16.85b USD (from longTermDebt, last quarter)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 139.07b USD (127.71b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.50b / Interest Expense TTM 602.6m)
EV/FCF = 50.16x (Enterprise Value 139.07b / FCF TTM 2.77b)
FCF Yield = 1.99% (FCF TTM 2.77b / Enterprise Value 139.07b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.34 (Enterprise Value 139.07b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.44b (EBIT 1.50b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.24 (Net Debt 11.36b / EBITDA 3.50b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.77% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.89% (EBIT 1.50b / Capital Employed (Equity 35.14b + L.T.Debt 16.85b))
RoIC = 2.81% (NOPAT 1.44b / Invested Capital 51.15b)
WACC = 6.24% (E(127.71b)/V(145.88b) * Re(7.01%) + D(18.16b)/V(145.88b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 7.01% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 86.88% ; FCFF base≈2.42b ; Y1≈2.88b ; Y5≈4.54b
Fair Price DCF = 156.7 (EV 118.88b - Net Debt 11.36b = Equity 107.52b / Shares 686.3m; r=6.24% [WACC]; 5y FCF grow 20.56% → 2.90% )
EPS Correlation: 50.83 | EPS CAGR: -36.58% | SUE: -3.55 | # QB: 0
Revenue Correlation: 97.75 | Revenue CAGR: 21.45% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=-0.041 | Revisions Net=+2 | Analysts=6
EPS next Year (2026-12-31): EPS=2.18 | Chg30d=-0.250 | Revisions Net=+0 | Growth EPS=+42.1% | Growth Revenue=+17.9%

Additional Sources for WELL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle